RNA interference: Gene silencing in the fast lane

Seminars in Cancer Biology

Volumn 13, Issue 4, 2003, Pages 259-265

  Kittler, Ralf ^a   Buchholz, Frank ^a  

^a MAX PLANCK INSTITUTE OF MOLECULAR CELL BIOLOGY AND GENETICS   (Germany)

Author keywords

Gene silencing; RNAi; RNase III; siRNA; Whole embryo culture

Indexed keywords

DOUBLE STRANDED RNA; HYBRID PROTEIN; INTERFERON; ISOENZYME; PROTEIN KINASE R; RIBONUCLEASE III; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

APOPTOSIS; CAENORHABDITIS ELEGANS; CANCER DIAGNOSIS; CANCER GENETICS; CELL CYCLE; CELL PROLIFERATION; CHROMATIN; COST BENEFIT ANALYSIS; DNA MICROARRAY; ELECTROPORATION; EMBRYO CULTURE; EMBRYO DEVELOPMENT; GENE DELIVERY SYSTEM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE SILENCING; GENE TECHNOLOGY; GENETIC CODE; GENETIC TRANSFECTION; GENOME ANALYSIS; HUMAN; MAMMAL CELL; NIDATION; NONHUMAN; ONCOGENE; REVIEW; RNA DEGRADATION; RNA INTERFERENCE; RNA SYNTHESIS; RNA TRANSCRIPTION; SCREENING; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; VIRUS CARCINOGENESIS; ANIMAL; BIOSYNTHESIS; GENE THERAPY; GENETICS; METHODOLOGY; NEOPLASM; PHYSIOLOGY;

ANIMALS; GENE THERAPY; HUMANS; NEOPLASMS; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 0642307773     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1044-579X(03)00039-7     Document Type: Article

References (82)

1. Court D.L., Sawitzke J.A., Thomason L.C. Genetic engineering using homologous recombination. Annu. Rev. Genet. 36:2002;361-388.
2. Baudin A., Ozier-Kalogeropoulos O., Denouel A., Lacroute F., Cullin C. A simple and efficient method for direct gene deletion in Saccharomyces cerevisiae. Nucleic Acids Res. 21:1993;3329-3330.
3. Sonoda E., Morrison C., Yamashita Y.M., Takata M., Takeda S. Reverse genetic studies of homologous DNA recombination using the chicken B-lymphocyte line, DT40. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 356:2001;111-117.
4. Buerstedde J.M., Arakawa H., Watahiki A., Carninci P.P., Hayashizaki Y.Y., Korn B.et al. The DT40 web site: sampling and connecting the genes of a B cell line. Nucleic Acids Res. 30:2002;230-231.
5. Ledermann B. Embryonic stem cells and gene targeting. Exp. Physiol. 85:2000;603-613.
6. Kuhn R., Schwenk F. Conditional knockout mice. Methods Mol. Biol. 209:2003;159-185.
7. Goodchild J. Hammerhead ribozymes: biochemical and chemical considerations. Curr. Opin. Mol. Ther. 2:2000;272-281.
8. Kushner D.M., Silverman R.H. Antisense cancer therapy: the state of the science. Curr. Oncol. Rep. 2:2000;23-30.
9. Hannon G.J. RNA interference. Nature. 418:2002;244-251.
10. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 391:1998;806-811.
11. Gonczy P., Echeverri C., Oegema K., Coulson A., Jones S.J., Copley R.R. et al. Functional genomic analysis of cell division in C. elegans using RNAi of genes on chromosome III. Nature. 408:2000;331-336.
12. Fraser A.G., Kamath R.S., Zipperlen P., Martinez-Campos M., Sohrmann M., Ahringer J. Functional genomic analysis of C. elegans chromosome I by systematic RNA interference. Nature. 408:2000;325-330.
13. Kamath R.S., Fraser A.G., Dong Y., Poulin G., Durbin R., Gotta M.et al. Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature. 421:2003;231-237.
14. Tabara H., Grishok A., Mello C.C. RNAi in C. elegans: soaking in the genome sequence. Science. 282:1998;430-431.
15. Vaucheret H., Beclin C., Fagard M. Post-transcriptional gene silencing in plants. J. Cell Sci. 114:2001;3083-3091.
16. Clemens J.C., Worby C.A., Simonson-Leff N., Muda M., Maehama T., Hemmings B.A.et al. Use of double-stranded RNA interference in Drosophila cell lines to dissect signal transduction pathways. Proc. Natl. Acad. Sci. U.S.A. 97:2000;6499-6503.
17. Lachner M., Jenuwein T. The many faces of histone lysine methylation. Curr. Opin. Cell Biol. 14:2002;286-298.
18. McManus M.T., Sharp P.A. Gene silencing in mammals by small interfering RNAs. Nat. Rev. Genet. 3:2002;737-747.
19. Williams B.R. PKR; a sentinel kinase for cellular stress. Oncogene. 18:1999;6112-6120.
20. Stark G.R., Kerr I.M., Williams B.R., Silverman R.H., Schreiber R.D. How cells respond to interferons. Annu. Rev. Biochem. 67:1998;227-264.
21. Zamore P.D., Tuschl T., Sharp P.A., Bartel D.P. RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell. 101:2000;25-33.
22. Hammond S.M., Bernstein E., Beach D., Hannon G.J. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature. 404:2000;293-296.
23. Yang D., Lu H., Erickson J.W. Evidence that processed small dsRNAs may mediate sequence-specific mRNA degradation during RNAi in Drosophila embryos. Curr. Biol. 10:2000;1191-1200.
24. Bernstein E., Caudy A.A., Hammond S.M., Hannon G.J. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature. 409:2001;363-366.
25. Elbashir S.M., Lendeckel W., Tuschl T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 15:2001;188-200.
26. Conrad C., Rauhut R. Ribonuclease III: new sense from nuisance. Int. J. Biochem. Cell Biol. 34:2002;116-129.
27. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 411:2001;494-498.
28. Elbashir S.M., Martinez J., Patkaniowska A., Lendeckel W., Tuschl T. Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J. 20:2001;6877-6888.
29. Yang D., Buchholz F., Huang Z., Goga A., Chen C.Y., Brodsky F.M.et al. Short RNA duplexes produced by hydrolysis with Escherichia coli RNase III mediate effective RNA interference in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 99:2002;9942-9947.
30. Abbott A. Gene centre chips in with better route to microarrays. Nature. 420:2002;3.
31. Caplen N.J., Parrish S., Imani F., Fire A., Morgan R.A. Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc. Natl. Acad. Sci. U.S.A. 98:2001;9742-9747.
32. Jacque J.M., Triques K., Stevenson M. Modulation of HIV-1 replication by RNA interference. Nature. 418:2002;435-438.
33. McManus M.T., Haines B.B., Dillon C.P., Whitehurst C.E., van Parijs L., Chen J.et al. Small interfering RNA-mediated gene silencing in T lymphocytes. J. Immunol. 169:2002;5754-5760.
34. Barton G.M., Medzhitov R. Retroviral delivery of small interfering RNA into primary cells. Proc. Natl. Acad. Sci. U.S.A. 99:2002;14943-14945.
35. Zou X., Ray D., Aziyu A., Christov K., Boiko A.D., Gudkov A.V.et al. Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence. Genes Dev. 16:2002;2923-2934.
36. Krichevsky A.M., Kosik K.S. RNAi functions in cultured mammalian neurons. Proc. Natl. Acad. Sci. U.S.A. 99:2002;11926-11929.
37. Varambally S., Dhanasekaran S.M., Zhou M., Barrette T.R., Kumar-Sinha C., Sanda M.G.et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature. 419:2002;624-629.
38. Grishok A., Mello C.C. RNAi (Nematodes: Caenorhabditis elegans). Adv. Genet. 46:2002;339-360.
39. Winston W.M., Molodowitch C., Hunter C.P. Systemic RNAi in C. elegans requires the putative transmembrane protein SID-1. Science. 295:2002;2456-2459.
40. Herzig M., Christofori G. Recent advances in cancer research: mouse models of tumorigenesis. Biochim. Biophys. Acta. 1602:2002;97-113.
41. Bedell M.A., Jenkins N.A., Copeland N.G. Mouse models of human disease. Part I. Techniques and resources for genetic analysis in mice. Genes Dev. 11:1997;1-10.
42. Bedell M.A., Largaespada D.A., Jenkins N.A., Copeland N.G. Mouse models of human disease. Part II. Recent progress and future directions. Genes Dev. 11:1997;11-43.
43. Lewis D.L., Hagstrom J.E., Loomis A.G., Wolff J.A., Herweijer H. Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nat. Genet. 32:2002;107-108.
44. McCaffrey A.P., Meuse L., Pham T.T., Conklin D.S., Hannon G.J., Kay M.A. RNA interference in adult mice. Nature. 418:2002;38-39.
45. Zhang G., Budker V., Wolff J.A. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum. Gene Ther. 10:1999;1735-1737.
46. Liu F., Song Y., Liu D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. 6:1999;1258-1266.
47. Xia H., Mao Q., Paulson H.L., Davidson B.L. siRNA-mediated gene silencing in vitro and in vivo. Nat. Biotechnol. 20:2002;1006-1010.
48. Hasuwa H., Kaseda K., Einarsdottir T., Okabe M. Small interfering RNA and gene silencing in transgenic mice and rats. FEBS Lett. 532:2002;227-230.
49. Bertrand J.R., Pottier M., Vekris A., Opolon P., Maksimenko A., Malvy C. Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo. Biochem. Biophys. Res. Commun. 296:2002;1000-1004.
50. Wianny F., Zernicka-Goetz M. Specific interference with gene function by double-stranded RNA in early mouse development. Nat. Cell Biol. 2:2000;70-75.
51. Svoboda P., Stein P., Hayashi H., Schultz R.M. Selective reduction of dormant maternal mRNAs in mouse oocytes by RNA interference. Development. 127:2000;4147-4156.
52. Kim M.H., Yuan X., Okumura S., Ishikawa F. Successful inactivation of endogenous Oct-3/4 and c-mos genes in mouse preimplantation embryos and oocytes using short interfering RNAs. Biochem. Biophys. Res. Commun. 296:2002;1372-1377.
53. Calegari F., Haubensak W., Yang D., Huttner W.B., Buchholz F. Tissue-specific RNA interference in postimplantation mouse embryos with endoribonuclease-prepared short interfering RNA. Proc. Natl. Acad. Sci. U.S.A. 99:2002;14236-14240.
54. Cockroft DL. In: Copp AJ, Cockroft DL, editors. Postimplantation mammalian embryos. Oxford: IRL; 1990. p. 15-40.
55. Osumi N., Inoue T. Gene transfer into cultured mammalian embryos by electroporation. Methods. 24:2001;35-42.
56. Takahashi M., Sato K., Nomura T., Osumi N. Manipulating gene expressions by electroporation in the developing brain of mammalian embryos. Differentiation. 70:2002;155-162.
57. Oback B, Cid-Arregui A, Huttner WB. In: Garcia-Carranca AC-AA, editor. Viral vectors: basic science and gene therapy. Natick: Eaton Publishing; 2000. p. 277-93.
58. Marshall E. Gene therapy. Second child in French trial is found to have leukemia. Science. 299:2003;320.
59. Micura R. Small interfering RNAs and their chemical synthesis. Angew Chem. Int. Ed. Engl. 41:2002;2265-2269.
60. Yu J.Y., DeRuiter S.L., Turner D.L. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 99:2002;6047-6052.
61. Paddison P.J., Caudy A.A., Bernstein E., Hannon G.J., Conklin D.S. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev. 16:2002;948-958.
62. Brummelkamp T.R., Bernards R., Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science. 296:2002;550-553.
63. Paul C.P., Good P.D., Winer I., Engelke D.R. Effective expression of small interfering RNA in human cells. Nat. Biotechnol. 20:2002;505-508.
64. Miyagishi M., Taira K. U6 promoter-driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells. Nat. Biotechnol. 20:2002;497-500.
65. Sui G., Soohoo C., Affar el B., Gay F., Shi Y., Forrester W.C. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 99:2002;5515-5520.
66. Robert M.F., Morin S., Beaulieu N., Gauthier F., Chute I.C., Barsalou A.et al. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Nat. Genet. 33:2003;61-65.
67. Bakker J., Lin X., Nelson W.G. Methyl-CpG binding domain protein 2 represses transcription from hypermethylated pi-class glutathione-S-transferase gene promoters in hepatocellular carcinoma cells. J. Biol. Chem. 277:2002;22573-22580.
68. DiTullio R.A. Jr., Mochan T.A., Venere M., Bartkova J., Sehested M., Bartek J.et al. 53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer. Nat. Cell Biol. 4:2002;998-1002.
69. Wang B., Matsuoka S., Carpenter P.B., Elledge S.J. 53BP1, a mediator of the DNA damage checkpoint. Science. 298:2002;1435-1438.
70. Lee J.C., Schickling O., Stegh A.H., Oshima R.G., Dinsdale D., Cohen G.M.et al. DEDD regulates degradation of intermediate filaments during apoptosis. J. Cell Biol. 158:2002;1051-1066.
71. Lassus P., Opitz-Araya X., Lazebnik Y. Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization. Science. 297:2002;1352-1354.
72. Kartasheva N.N., Contente A., Lenz-Stoppler C., Roth J., Dobbelstein M. p53 induces the expression of its antagonist p73 Delta N, establishing an autoregulatory feedback loop. Oncogene. 21:2002;4715-4727.
73. Zhang D., Li F., Weidner D., Mnjoyan Z.H., Fujise K. Physical and functional interaction between myeloid cell leukemia 1 protein (MCL1) and Fortilin. The potential role of MCL1 as a fortilin chaperone. J. Biol. Chem. 277:2002;37430-37438.
74. Yoon H.S., Chen X., Yang V.W. Kruppel-like factor 4 mediates p53-dependent G1/S cell cycle arrest in response to DNA damage. J. Biol. Chem. 278:2003;2101-2105.
75. Chen Z., Indjeian V.B., McManus M., Wang L., Dynlacht B.D. CP110, a cell cycle-dependent CDK substrate, regulates centrosome duplication in human cells. Dev. Cell. 3:2002;339-350.
76. Porter L.A., Dellinger R.W., Tynan J.A., Barnes E.A., Kong M., Leromand J.L.et al. Human speedy: a novel cell cycle regulator that enhances proliferation through activation of Cdk2. J. Cell Biol. 157:2002;357-366.
77. Debes J.D., Schmidt L.J., Huang H., Tindall D.J. P300 mediates androgen-independent transactivation of the androgen receptor by interleukin 6. Cancer Res. 62:2002;5632-5636.
78. Shu X., Wu W., Mosteller R.D., Broek D. Sphingosine kinase mediates vascular endothelial growth factor-induced activation of ras and mitogen-activated protein kinases. Mol. Cell. Biol. 22:2002;7758-7768.
79. Liu J., Yao F., Wu R., Morgan M., Thorburn A., Finley R.L. Jr.et al. Mediation of the DCC apoptotic signal by DIP13 alpha. J. Biol. Chem. 277:2002;26281-26285.
80. Jiang M., Milner J. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Oncogene. 21:2002;6041-6048.
81. Heidenreich O., Krauter J., Riehle H., Hadwiger P., John M., Heil G.et al. AML1/MTG8 oncogene suppression by small interfering RNAs supports myeloid differentiation of t(8;21)-positive leukemic cells. Blood. 101:2003;3157-3163.
82. Scherr M., Battmer K., Winkler T., Heidenreich O., Ganser A., Eder M. Specific inhibition of bcr-abl gene expression by small interfering RNA. Blood. 101:2003;1566-1599.